Brazil Decides to Make Own AIDS Drug After Talks With Merck Collapse

AIDS generic pills Until the end of the year, Brazil's Lafepe, the pharmaceutical laboratory of the Brazilian northeastern state of Pernambuco will start production of 30 million units of the medication Efavirenz. The medicine is used in aids treatment. The production in the state lab will be possible thanks to a partnership with the Farmanguinhos (Pharmaceutical Technology Institute), which belongs to Rio de Janeiro's Fiocruz (Oswaldo Cruz Foundation).

With this measure, the medicine, which is manufactured today by the multinational laboratory Merck Sharp & Dohme, will have its cost reduced by up to 40%, according to the technical director of Pernambuco's state-run lab, David Santana.

The product will be distributed by the Brazilian Health ministry to the whole country as part of the National Program of Sexually Transmissible Diseases and Aids.

In order for the Lafepe to start manufacturing the Efavirenz, the Health ministry declared the medicine to be of public interest, the first step for the compulsory licensing of the patent.

The procedure, contemplated by Brazilian industrial ownership law, is used by developed or in-development countries in cases of abuse of economic power by the patent owner, as well as when there is a national emergency or public interest, as long as the negotiations with the company have been exhausted.

"The measure is not a patent breakage but a compulsory suspension," explains Lafepe's director. The federal government spends about US$ 580 per patient to purchase the medication, every year. Until the national production of Efavirenz is normalized, the Health Department intends to import the medicine, in its generic formula, from international laboratories which are recommended by the World Health Organization (WHO).

Negotiation between Merck and the Brazilian government seem to have arrived at an impasse. While Brazil has asked Merck to lower the price of Efavirenz to $0.65 per pill – the price Thailand pays – the New Jersey based drug maker refuse to lower beyond US$ 1.10.

Brazil's Health ministry says that Brazil is paying US$ 1.57 per pill now.  Merck informs that they sell the drug for US$ 1.80 in most middle-income countries, like Brazil.

"We at Merck are disappointed to have had what we considered to be a fair offer rejected by the government of Brazil," Merck spokeswoman Amy Rose told reporters.

Since 1990, the Lafepe manufactures six products for the Health ministry for aids treatment. Among them there are Lamivudina, Zidovudina and Estavudina. Other public labs in the country, like Farmanguinhos, from Rio de Janeiro, Funed, from Minas Gerais, Furpe, from São Paulo, and Iquego, from Goiás, also produce medications used to treat AIDS patients.

Data from the Health ministry show that from about 200,000 people who are being treated for aids in Brazil, 38% use the imported drug Efavirenz.

In the northeastern state of Pernambuco alone, there are 4,400 AIDS patients registered to receive antiretroviral free medications as well as drugs to fight opportunistic diseases, like tuberculosis. These medicines are supplied by the Health ministry and state governments.

ABr

Tags:

Ads

You May Also Like

Light out of Darkness

A country where the population can reduce by 20 percent the domestic consumption of ...

Amnesty Warns: ‘Blood Bath Imminent in Rio’s Favelas’

Unless the authorities in Rio de Janeiro, Brazil, take immediate steps to restore order ...

US dollar and Brazilian real

Weak Dollar Brings Brazil to the Rescue of Industry

The commercial dollar recovered a little ground today in Brazil after the Brazilian currency, ...

Attorney General Says Brazil’s Biosecurity Law Is Unconstitutional

Brazil’s Federal Supreme Court (STF) received a petition of Direct Action of Unconstitutionality (ADI) ...

Brazil’s Lula Calls Himself the Best Qualified to Do War on Corruption

Brazilian President Luiz Inácio Lula da Silva said today that nobody has bigger ethical ...

Not Since the Dinosaurs Demise Species Had It So Bad, Say Experts in Brazil

Brazil announced plans to expand protection of the Amazon rain forest, as cabinet ministers ...

Cry of Excluded Brings Brazilians to the Streets

The traditional Independence Day march of the “Cry of the Excluded” brought some 6,000 ...

Petrobras Will Export Less Gasoline to Supply Brazilian Market

Drivers in Brazil have the following choices when they fill up: gasoline with a ...

A Plan to Juice Up Brazil’s Fruit Exports

Brazilian fruit industries want to produce and export more fruit juice. For this reason, ...

Despite Oil Prices Brazil’s Market Reaches New Heights

Brazilian stocks advanced, in spite of a rise in global oil prices. Crude oil ...